img

Global Synthetic Oligonucleotides Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Synthetic Oligonucleotides Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.
Synthetic Oligonucleotides report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Synthetic Oligonucleotides market is projected to reach US$ 14260 million in 2033, increasing from US$ 6782 million in 2022, with the CAGR of 11.2% during the period of 2023 to 2033. Demand from Genetic Testing and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Synthetic Oligonucleotides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Synthetic Oligonucleotides key companies include Merck KGaA, Thermo Fisher Scientific, Creative Biolabs, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., GE Healthcare, Kaneka Eurogentec S.A. and GeneDesign, Inc., etc. Merck KGaA, Thermo Fisher Scientific, Creative Biolabs are top 3 players and held % share in total in 2022.
Synthetic Oligonucleotides can be divided into Column-Based Oligos and Array-Based Oligos, etc. Column-Based Oligos is the mainstream product in the market, accounting for % share globally in 2022.
Synthetic Oligonucleotides is widely used in various fields, such as Genetic Testing, Pharmacy and Other,, etc. Genetic Testing provides greatest supports to the Synthetic Oligonucleotides industry development. In 2022, global % share of Synthetic Oligonucleotides went into Genetic Testing filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Synthetic Oligonucleotides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience
Segment by Type
Column-Based Oligos
Array-Based Oligos

Segment by Application


Genetic Testing
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Synthetic Oligonucleotides market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Synthetic Oligonucleotides introduction, etc. Synthetic Oligonucleotides Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Synthetic Oligonucleotides market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Synthetic Oligonucleotides
1.1 Synthetic Oligonucleotides Market Overview
1.1.1 Synthetic Oligonucleotides Product Scope
1.1.2 Synthetic Oligonucleotides Market Status and Outlook
1.2 Global Synthetic Oligonucleotides Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Synthetic Oligonucleotides Market Size by Region (2018-2033)
1.4 Global Synthetic Oligonucleotides Historic Market Size by Region (2018-2023)
1.5 Global Synthetic Oligonucleotides Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Synthetic Oligonucleotides Market Size (2018-2033)
1.6.1 North America Synthetic Oligonucleotides Market Size (2018-2033)
1.6.2 Europe Synthetic Oligonucleotides Market Size (2018-2033)
1.6.3 Asia-Pacific Synthetic Oligonucleotides Market Size (2018-2033)
1.6.4 Latin America Synthetic Oligonucleotides Market Size (2018-2033)
1.6.5 Middle East & Africa Synthetic Oligonucleotides Market Size (2018-2033)
2 Synthetic Oligonucleotides Market by Type
2.1 Introduction
2.1.1 Column-Based Oligos
2.1.2 Array-Based Oligos
2.2 Global Synthetic Oligonucleotides Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Synthetic Oligonucleotides Historic Market Size by Type (2018-2023)
2.2.2 Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Synthetic Oligonucleotides Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Synthetic Oligonucleotides Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Synthetic Oligonucleotides Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Synthetic Oligonucleotides Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Synthetic Oligonucleotides Revenue Breakdown by Type (2018-2033)
3 Synthetic Oligonucleotides Market Overview by Application
3.1 Introduction
3.1.1 Genetic Testing
3.1.2 Pharmacy
3.1.3 Other
3.2 Global Synthetic Oligonucleotides Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Synthetic Oligonucleotides Historic Market Size by Application (2018-2023)
3.2.2 Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Synthetic Oligonucleotides Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Synthetic Oligonucleotides Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Synthetic Oligonucleotides Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Synthetic Oligonucleotides Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Synthetic Oligonucleotides Revenue Breakdown by Application (2018-2033)
4 Synthetic Oligonucleotides Competition Analysis by Players
4.1 Global Synthetic Oligonucleotides Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
4.3 Date of Key Players Enter into Synthetic Oligonucleotides Market
4.4 Global Top Players Synthetic Oligonucleotides Headquarters and Area Served
4.5 Key Players Synthetic Oligonucleotides Product Solution and Service
4.6 Competitive Status
4.6.1 Synthetic Oligonucleotides Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Profile
5.1.2 Merck KGaA Main Business
5.1.3 Merck KGaA Synthetic Oligonucleotides Products, Services and Solutions
5.1.4 Merck KGaA Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.1.5 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Synthetic Oligonucleotides Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Creative Biolabs
5.3.1 Creative Biolabs Profile
5.3.2 Creative Biolabs Main Business
5.3.3 Creative Biolabs Synthetic Oligonucleotides Products, Services and Solutions
5.3.4 Creative Biolabs Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Corporation Recent Developments
5.4 Danaher Corporation
5.4.1 Danaher Corporation Profile
5.4.2 Danaher Corporation Main Business
5.4.3 Danaher Corporation Synthetic Oligonucleotides Products, Services and Solutions
5.4.4 Danaher Corporation Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Corporation Recent Developments
5.5 Eurofins Scientific SE
5.5.1 Eurofins Scientific SE Profile
5.5.2 Eurofins Scientific SE Main Business
5.5.3 Eurofins Scientific SE Synthetic Oligonucleotides Products, Services and Solutions
5.5.4 Eurofins Scientific SE Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Scientific SE Recent Developments
5.6 Agilent Technologies, Inc.
5.6.1 Agilent Technologies, Inc. Profile
5.6.2 Agilent Technologies, Inc. Main Business
5.6.3 Agilent Technologies, Inc. Synthetic Oligonucleotides Products, Services and Solutions
5.6.4 Agilent Technologies, Inc. Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies, Inc. Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Synthetic Oligonucleotides Products, Services and Solutions
5.7.4 GE Healthcare Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Kaneka Eurogentec S.A.
5.8.1 Kaneka Eurogentec S.A. Profile
5.8.2 Kaneka Eurogentec S.A. Main Business
5.8.3 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Products, Services and Solutions
5.8.4 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.8.5 Kaneka Eurogentec S.A. Recent Developments
5.9 GeneDesign, Inc.
5.9.1 GeneDesign, Inc. Profile
5.9.2 GeneDesign, Inc. Main Business
5.9.3 GeneDesign, Inc. Synthetic Oligonucleotides Products, Services and Solutions
5.9.4 GeneDesign, Inc. Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.9.5 GeneDesign, Inc. Recent Developments
5.10 LGC Biosearch Technologies
5.10.1 LGC Biosearch Technologies Profile
5.10.2 LGC Biosearch Technologies Main Business
5.10.3 LGC Biosearch Technologies Synthetic Oligonucleotides Products, Services and Solutions
5.10.4 LGC Biosearch Technologies Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.10.5 LGC Biosearch Technologies Recent Developments
5.11 Bio-synthesis Inc.
5.11.1 Bio-synthesis Inc. Profile
5.11.2 Bio-synthesis Inc. Main Business
5.11.3 Bio-synthesis Inc. Synthetic Oligonucleotides Products, Services and Solutions
5.11.4 Bio-synthesis Inc. Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.11.5 Bio-synthesis Inc. Recent Developments
5.12 GeneWorks Pty Ltd
5.12.1 GeneWorks Pty Ltd Profile
5.12.2 GeneWorks Pty Ltd Main Business
5.12.3 GeneWorks Pty Ltd Synthetic Oligonucleotides Products, Services and Solutions
5.12.4 GeneWorks Pty Ltd Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.12.5 GeneWorks Pty Ltd Recent Developments
5.13 Integrated DNA Technologies, Inc
5.13.1 Integrated DNA Technologies, Inc Profile
5.13.2 Integrated DNA Technologies, Inc Main Business
5.13.3 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Products, Services and Solutions
5.13.4 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.13.5 Integrated DNA Technologies, Inc Recent Developments
5.14 BioAutomation
5.14.1 BioAutomation Profile
5.14.2 BioAutomation Main Business
5.14.3 BioAutomation Synthetic Oligonucleotides Products, Services and Solutions
5.14.4 BioAutomation Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.14.5 BioAutomation Recent Developments
5.15 Twist Bioscience
5.15.1 Twist Bioscience Profile
5.15.2 Twist Bioscience Main Business
5.15.3 Twist Bioscience Synthetic Oligonucleotides Products, Services and Solutions
5.15.4 Twist Bioscience Synthetic Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.15.5 Twist Bioscience Recent Developments
6 North America
6.1 North America Synthetic Oligonucleotides Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Synthetic Oligonucleotides Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Synthetic Oligonucleotides Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Synthetic Oligonucleotides Market Dynamics
11.1 Synthetic Oligonucleotides Industry Trends
11.2 Synthetic Oligonucleotides Market Drivers
11.3 Synthetic Oligonucleotides Market Challenges
11.4 Synthetic Oligonucleotides Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Synthetic Oligonucleotides Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Synthetic Oligonucleotides Market Size Share by Region (2018-2023)
Table 4. Global Synthetic Oligonucleotides Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Synthetic Oligonucleotides Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Synthetic Oligonucleotides Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Synthetic Oligonucleotides Revenue Market Share by Type (2018-2023)
Table 9. Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Synthetic Oligonucleotides Revenue Market Share by Type (2024-2033)
Table 11. North America Synthetic Oligonucleotides Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Synthetic Oligonucleotides Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Synthetic Oligonucleotides Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Synthetic Oligonucleotides Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Synthetic Oligonucleotides Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Synthetic Oligonucleotides Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Synthetic Oligonucleotides Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Synthetic Oligonucleotides Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Synthetic Oligonucleotides Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Synthetic Oligonucleotides Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Synthetic Oligonucleotides Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Synthetic Oligonucleotides Revenue Market Share by Application (2018-2023)
Table 24. Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Synthetic Oligonucleotides Revenue Market Share by Application (2024-2033)
Table 26. North America Synthetic Oligonucleotides Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Synthetic Oligonucleotides Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Synthetic Oligonucleotides Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Synthetic Oligonucleotides Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Synthetic Oligonucleotides Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Synthetic Oligonucleotides Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Synthetic Oligonucleotides Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Synthetic Oligonucleotides Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Synthetic Oligonucleotides Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Synthetic Oligonucleotides Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Synthetic Oligonucleotides Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Synthetic Oligonucleotides Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
Table 39. Date of Key Players Enter into Synthetic Oligonucleotides Market
Table 40. Global Synthetic Oligonucleotides Key Players Headquarters and Area Served
Table 41. Synthetic Oligonucleotides Product Solution and Service
Table 42. Global Synthetic Oligonucleotides Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck KGaA Basic Information List
Table 45. Merck KGaA Description and Business Overview
Table 46. Merck KGaA Synthetic Oligonucleotides Products, Services and Solutions
Table 47. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Merck KGaA (2018-2023)
Table 48. Merck KGaA Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific Synthetic Oligonucleotides Products, Services and Solutions
Table 52. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Thermo Fisher Scientific (2018-2023)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. Creative Biolabs Basic Information List
Table 55. Creative Biolabs Description and Business Overview
Table 56. Creative Biolabs Synthetic Oligonucleotides Products, Services and Solutions
Table 57. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Creative Biolabs (2018-2023)
Table 58. Creative Biolabs Recent Developments
Table 59. Danaher Corporation Basic Information List
Table 60. Danaher Corporation Description and Business Overview
Table 61. Danaher Corporation Synthetic Oligonucleotides Products, Services and Solutions
Table 62. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Danaher Corporation (2018-2023)
Table 63. Danaher Corporation Recent Developments
Table 64. Eurofins Scientific SE Basic Information List
Table 65. Eurofins Scientific SE Description and Business Overview
Table 66. Eurofins Scientific SE Synthetic Oligonucleotides Products, Services and Solutions
Table 67. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Eurofins Scientific SE (2018-2023)
Table 68. Eurofins Scientific SE Recent Developments
Table 69. Agilent Technologies, Inc. Basic Information List
Table 70. Agilent Technologies, Inc. Description and Business Overview
Table 71. Agilent Technologies, Inc. Synthetic Oligonucleotides Products, Services and Solutions
Table 72. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Agilent Technologies, Inc. (2018-2023)
Table 73. Agilent Technologies, Inc. Recent Developments
Table 74. GE Healthcare Basic Information List
Table 75. GE Healthcare Description and Business Overview
Table 76. GE Healthcare Synthetic Oligonucleotides Products, Services and Solutions
Table 77. Revenue (US$ Million) in Synthetic Oligonucleotides Business of GE Healthcare (2018-2023)
Table 78. GE Healthcare Recent Developments
Table 79. Kaneka Eurogentec S.A. Basic Information List
Table 80. Kaneka Eurogentec S.A. Description and Business Overview
Table 81. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Products, Services and Solutions
Table 82. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Kaneka Eurogentec S.A. (2018-2023)
Table 83. Kaneka Eurogentec S.A. Recent Developments
Table 84. GeneDesign, Inc. Basic Information List
Table 85. GeneDesign, Inc. Description and Business Overview
Table 86. GeneDesign, Inc. Synthetic Oligonucleotides Products, Services and Solutions
Table 87. Revenue (US$ Million) in Synthetic Oligonucleotides Business of GeneDesign, Inc. (2018-2023)
Table 88. GeneDesign, Inc. Recent Developments
Table 89. LGC Biosearch Technologies Basic Information List
Table 90. LGC Biosearch Technologies Description and Business Overview
Table 91. LGC Biosearch Technologies Synthetic Oligonucleotides Products, Services and Solutions
Table 92. Revenue (US$ Million) in Synthetic Oligonucleotides Business of LGC Biosearch Technologies (2018-2023)
Table 93. LGC Biosearch Technologies Recent Developments
Table 94. Bio-synthesis Inc. Basic Information List
Table 95. Bio-synthesis Inc. Description and Business Overview
Table 96. Bio-synthesis Inc. Synthetic Oligonucleotides Products, Services and Solutions
Table 97. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Bio-synthesis Inc. (2018-2023)
Table 98. Bio-synthesis Inc. Recent Developments
Table 99. GeneWorks Pty Ltd Basic Information List
Table 100. GeneWorks Pty Ltd Description and Business Overview
Table 101. GeneWorks Pty Ltd Synthetic Oligonucleotides Products, Services and Solutions
Table 102. Revenue (US$ Million) in Synthetic Oligonucleotides Business of GeneWorks Pty Ltd (2018-2023)
Table 103. GeneWorks Pty Ltd Recent Developments
Table 104. Integrated DNA Technologies, Inc Basic Information List
Table 105. Integrated DNA Technologies, Inc Description and Business Overview
Table 106. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Products, Services and Solutions
Table 107. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Integrated DNA Technologies, Inc (2018-2023)
Table 108. Integrated DNA Technologies, Inc Recent Developments
Table 109. BioAutomation Basic Information List
Table 110. BioAutomation Description and Business Overview
Table 111. BioAutomation Synthetic Oligonucleotides Products, Services and Solutions
Table 112. Revenue (US$ Million) in Synthetic Oligonucleotides Business of BioAutomation (2018-2023)
Table 113. BioAutomation Recent Developments
Table 114. Twist Bioscience Basic Information List
Table 115. Twist Bioscience Description and Business Overview
Table 116. Twist Bioscience Synthetic Oligonucleotides Products, Services and Solutions
Table 117. Revenue (US$ Million) in Synthetic Oligonucleotides Business of Twist Bioscience (2018-2023)
Table 118. Twist Bioscience Recent Developments
Table 119. North America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 120. North America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 121. Europe Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 122. Europe Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 123. Asia-Pacific Synthetic Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 124. Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 125. Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2024-2033) & (US$ Million)
Table 126. Asia-Pacific Synthetic Oligonucleotides Market Share by Region (2018-2023)
Table 127. Asia-Pacific Synthetic Oligonucleotides Market Share by Region (2024-2033)
Table 128. Latin America Synthetic Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 129. Latin America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 130. Latin America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 131. Middle East & Africa Synthetic Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 132. Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 133. Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 134. Synthetic Oligonucleotides Market Trends
Table 135. Synthetic Oligonucleotides Market Drivers
Table 136. Synthetic Oligonucleotides Market Challenges
Table 137. Synthetic Oligonucleotides Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Oligonucleotides Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Synthetic Oligonucleotides Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Synthetic Oligonucleotides Market Share by Regions: 2022 VS 2033
Figure 4. Global Synthetic Oligonucleotides Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Synthetic Oligonucleotides Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Synthetic Oligonucleotides Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Synthetic Oligonucleotides Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Synthetic Oligonucleotides Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Synthetic Oligonucleotides Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Column-Based Oligos
Figure 11. Global Column-Based Oligos Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Array-Based Oligos
Figure 13. Global Array-Based Oligos Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Synthetic Oligonucleotides Market Size Share by Type: 2022 & 2033
Figure 15. North America Synthetic Oligonucleotides Revenue Market Share by Type (2018-2033)
Figure 16. Europe Synthetic Oligonucleotides Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Synthetic Oligonucleotides Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Synthetic Oligonucleotides Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Synthetic Oligonucleotides Revenue Market Share by Type (2018-2033)
Figure 20. Genetic Testing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Synthetic Oligonucleotides Market Size Share by Application: 2022 & 2033
Figure 24. North America Synthetic Oligonucleotides Revenue Market Share by Application (2018-2033)
Figure 25. Europe Synthetic Oligonucleotides Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Synthetic Oligonucleotides Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Synthetic Oligonucleotides Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Synthetic Oligonucleotides Revenue Market Share by Application (2018-2033)
Figure 29. Synthetic Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Synthetic Oligonucleotides Market Share in 2022
Figure 31. North America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 32. United States Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 35. France Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Synthetic Oligonucleotides Market Share by Region (2018-2033)
Figure 41. China Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 45. India Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 48. Mexico Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 51. Turkey Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Synthetic Oligonucleotides Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report